NICE recommends axunio’s Axhidrox cream for adults with severe hyperhydrosis
Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life
Read More
Aug 19, 2026 | News, Regulatory
Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life
Read MoreAug 18, 2026 | News, Regulatory
There are currently no approved human vaccines for Lyme disease
Read MoreAug 17, 2026 | News, Healthcare
The agreement for up to ten biosimilar assets represents one of largest ever biosimilar collaborations for the company
Read MoreAug 14, 2026 | News, Healthcare
Texas has been chosen as the site for a new, state-of-the-art multi-modal manufacturing campus
Read MoreAug 13, 2026 | News, Regulatory
The treatment uses peptides designed to retrain the immune system to tolerate peanuts
Read MoreAug 12, 2026 | News, Regulatory
NETs affect approximately seven per 100,000 people in Scotland
Read MoreAug 11, 2026 | News, Regulatory
The UK is the first country in Europe to authorise the oral medication
Read MoreAug 11, 2026 | News, Healthcare
The Awards are a leading celebration of excellence in healthcare partnership working
Read MoreAug 10, 2026 | News, Regulatory
The treatments are for eligible adults in England and Wales
Read MoreThe event runs from 6-8 October 2026 at the Fiera Milano exhibition centre in Rho, Italy
Read MoreAug 7, 2026 | News, Regulatory
The treatment is to protect children under two years of age from respiratory syncytial virus
Read MoreAug 6, 2026 | News, Healthcare
A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21
Read More
